Medical Affairs Specialist Elanco Animal Health University Place, Washington, United States
Disclosure(s):
Chris George, DVM: No relevant disclosure to display
This program provides an overview of canine parvovirus (CPV) and associated treatment. This discussion includes disease state for CPV, standard of care inpatient and outpatient treatment options, and a review of treatment options discussed in recent literature. An introduction and overview of Elanco’s Canine Parvovirus Monoclonal Antibody will be discussed.
Learning Objectives:
Recognize the impact of CPV on the patient, hospital, and owner.
Understand standard of care inpatient and outpatient treatment options.
Learn about recent treatment options discussed in the literature including a targeted Canine Parvovirus Monoclonal Antibody (CPMA) for CPV treatment.
Be confident implementing novel treatment options such as CPMA into various CPV treatment protocols.
.png)
